Научная литература
booksshare.net -> Добавить материал -> Медицина -> Насонов Е.Л. -> "Антифосфолипидный синдром" -> 136

Антифосфолипидный синдром - Насонов Е.Л.

Насонов Е.Л. Антифосфолипидный синдром — М.: Литтерра, 2004. — 440 c.
ISBN 5-98216-010-5
Скачать (прямая ссылка): antisindrom2004.pdf
Предыдущая << 1 .. 130 131 132 133 134 135 < 136 > 137 138 139 140 141 142 .. 184 >> Следующая

98. Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction. Circulation 1997; 96: 1432—1437.
99. Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 51—60.
100. Roman MJ, Salmon JE, Sobel R, et al. Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospho-lipid antibody syndrome. Am J Cardiol 2001; 87: 663—666.
101. Vlachoyinnopoulos PG, Kanellopoulos PG, Ioannidis JPA, et al. Atherosclerosis in pre-menopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology 1003; 42: 645—651.
102. Medina G, Casaos D, Jata LJ, et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003; 62: 607—610.
103. Ames PRL, Margarita A, Delgado Alves J, et al. Anticardiolipin antibodies and plasma homocysteine levels independently predict intima media thickness of carotid artery in subject with
SHS-OOO4.qxd 21.11.2006 16:56 Page З3ЗЗ
33
.ГЛАВА 12. Атеросклеротическое поражение сосудов при системной красной волчанке и АФС
idiopathic antiphospholipid syndrome. Lupus 2002; 11: 208—214.
104. Roman MJ, Shanker B-A, Loschin M, et al. Accelerated atherosclerosis in systemic lupus erythematosus: clinical correlations and time dependency. Arthritis Rheum 2002; (Suppl): 57, 40 (abst).
105. Font J, Jimenez S, Garcia-Criado A, et al. Atherosclerosis in SLE is associated with accumulative disease damage but not with traditional vascular risk factors. Arthritis Rheum 2002; (Suppl.): 58 (42 abst).
106. Romero-Diaz J, Barragan-Campos H, Romero C, et al. Atherosclerotic vascular disease in systemic lupus erythematosus (SLE). Yearly progression of the carotid intima-media thickness in the inception cohort. ACR/ARHP Annual Scientific Meeting October 24—28, 2003; 896 (abst).
107. Theodoridou A, Bento L, QCruz DP, et al. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythe-matosus; a pilot study. Ann Rheum Dis 2003; 62: 1199—1203.
108. Sella EM, Sato EI, Barbieri A. Coronary artery angiography in systemic lupus erythemato-sus patients with abnormal myocardial perfusion scintigraphy. Arthritis Rheum 2003; 48: 3168— 3175.
109. Atar S, Jean DS, Siegel RJ. Mitral annual calcification: a marker of severe coronary artery disease in patients under 65 years old. Heart 2003; 89: 161—164.
110. Rajamannan NM, Gersh B, Bonow RO. Calcific aortic stenosis: from bench to bedside — emerging clinical and cellular concept. Heart 2003; 89: 801—805.
111. Novard GM, Griffin BP. Calcific aortic stenosis: another face of atherosclerosis. Clev Clin J 2003; 70: 471—478.
112. Molad Y, Levin-Laina N, Vaturi M, et al. Increased prevalence of heart valve calcification in patients with systemic lupus erythematosus: a window to premature atherosclerotic vascular morbidity. ACR/ARHP Annual Scientific Meeting October 24—28, 2003; 895 (abst).
113. Petri M, Roubenoff R, Dallal GE, et al. Plasma homocystein as a risk factor for athero-thrombotic events in systemic lupus erythemato-sus. Lancet 1996; 348: 1120—1124.
114. Tam L-S. Fan B, Li EK, et al. Patients with systemic lupus erythematosus show increased platelet activatwn and endothelial dysfunction induced by acute hyperhomocysteinemia. J Rheumatol 2003; 30: 1479—1484.
115. Kabakov AE, Tertov VV, Saenko VA, et al. The atherogenic effect of lupus sera systemic lupus erythematosus-derived immune complexes stimulated the accumulation of cholesterol in cultured smoth muscle cellsfrom human aorta. Clin Immunol Immunopathol 1992; 63: 214—220.
116. Garrido JA, Peromingo JAD, Sesma P, Pia G. More about the link between thrombosis and atherosclerosis in autoimmune disease: trigli-cerides and risk for thrombosis in patients with antiphospholipid antibodies. J Rheumatol 1994; 21: 2394.
117. Jurado M, Paramo JA, Gutierrez-Pimentel M, et al. Fibrinolityc potential and antiphospho-lipid antibodies in systemic lupus erythematosus and other connective tissue disorders. Thromb Haemost 1992; 68: 516—520.
118. Yamazaki M, Asakura H, Jokaji H, et al. Plasma levels of lipoprotein (a) are elevated in patients with antiphospholipid antybody syndrome. Thromb Haemost 1994; 71: 424—427.
119. Nassonov E, Baranov A, Kovaliov V. Von Willebrand factor antigen and antiphos-pholipid antibodies in systemic lupus erythe-matosus. Clin Exp Rheumatol 1994; 12 (Suppl 11): 97 (abst).
120. George J, Harats D, Shoenfeld Y, et al. Induction of early atherosclerosis in LDL receptor deficient moce immunized with beta 2 glycopro-tein I. Circulation 1998; 15: 1108—1115.
121. Afek A, George J, Shoenfeld Y, et al. Enhanced atherosclerosis in apoE deficient mice by immunization with ?2-glycoprotein I. Path-obiology 1999; 67: 19—25.
Предыдущая << 1 .. 130 131 132 133 134 135 < 136 > 137 138 139 140 141 142 .. 184 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed